Literature DB >> 19332903

Acute leukemia/myelodysplastic syndrome as a sequelae of carcinoma breast: a report of five cases from north India.

Prateek Bhatia1, Reena Das, Jasmina Ahluwalia, Pankaj Malhotra, Neelam Varma, S Varma, S C Sharma, Gurjeewan Garewal.   

Abstract

A second malignant neoplasm has been found to be more frequent than might be expected from the general population rates. Therapy-related myelodysplastic syndrome and acute leukemia are dreaded long-term complications of five cases of hematological malignancies following treatment for successful breast cancer therapy (therapeutic drugs or radiotherapy). We encountered carcinoma from north India over a 7-year period from 1999 to 2005. The patients presented 2-5 years after treatment of breast carcinoma. Three patients underwent surgery and received chemoradiotherapy. One patient received chemotherapy after surgery. One patient underwent only surgery and after 3 years presented with acute myeloid leukemia and bone marrow metastasis of carcinoma of the breast. At the time of presentation, all the patients had either bicytopenia or pancytopenia. A close follow-up with complete blood cell counts of the patients who previously had carcinoma of the breast is suggested for early detection of hematological abnormalities. However, the poor prognosis, limited financial resources and poor health insurance coverage results in few patients and their family members opting for treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19332903     DOI: 10.4103/0377-4929.48908

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  2 in total

1.  Acute promyelocytic leukemia in a young patient with breast cancer.

Authors:  Ozgur Kara; Evren Ozdemir; Cagatay Arslan; Erkan Dogan; Kadri Altundag
Journal:  Med Oncol       Date:  2010-02-06       Impact factor: 3.064

2.  Treatment Related Acute Myeloid Leukemia in Breast Cancer Survivors: A Single Institutional Experience.

Authors:  Ilavarasi Vanidassane; Ajay Gogia; Vinod Raina; Ritu Gupta
Journal:  Indian J Hematol Blood Transfus       Date:  2019-02-04       Impact factor: 0.900

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.